Literature DB >> 7779262

Isolation and partial characterization of basic proteinases from stem bromelain.

T Harrach1, K Eckert, K Schulze-Forster, R Nuck, D Grunow, H R Maurer.   

Abstract

Crude bromelain extracts from pineapple stems (Ananas comosus) were fractionated by two-step FPLC-cation-exchange chromatography. At least eight basic proteolytically active components were detected. The two main components F4 and F5 together with the most active proteinase fraction F9 were characterized by SDS-PAGE, mass spectroscopy, multizonal cathodal electrophoresis, partial amino acid sequence, and monosaccharide composition analysis. F9 amounts to about 2% of the total protein and has a 15 times higher specific activity against the substrate L-pyroglutamyl-l-phenylanalyl-l-leucine-p-nitroanilide (PFLNA) than the main component F4. The molecular masses of F4, F5, and F9 were determined to 24,397, 24,472, and 23,427, respectively, by mass spectroscopy. Partial N-terminal amino acid sequence analysis (20 amino acids) revealed that F9 differs from the determined sequence of F4 and F5 by an exchange at position 10 (tyrosine-->serine) and position 20 (asparagine-->glycine). F4 and F5 contained fucose, N-acetylglucosamine, xylose, and mannose in ratio of 1.0:2.0:1.0:2.0, but only 50% of the proteins seem to be glycosylated, whereas F9 was found to be unglycosylated. Polyclonal antibodies (IgG) against F9 detected F4 and F5 with tenfold reduced reactivity. The pH optimum of F4 and F5 was between pH 4.0 and 4.5 and for F9 close to neutral pH. The kinetic parameters for PFLNA hydrolysis were similar for F4 (Km 2.30 mM, kcat 0.87 sec-1 and F5 (Km 2.42 mM, kcat 0.68 sec-1), and differed greatly from F9 (Km 0.40 mM, kcat 3.94 sec-1).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779262     DOI: 10.1007/bf01902843

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  19 in total

1.  Chromatographic separation according to size of macromolecules and cell particles on columns of agarose suspensions.

Authors:  S HJERTEN
Journal:  Arch Biochem Biophys       Date:  1962-12       Impact factor: 4.013

2.  Stem bromelain: amino acid sequence and implications for weak binding of cystatin.

Authors:  A Ritonja; A D Rowan; D J Buttle; N D Rawlings; V Turk; A J Barrett
Journal:  FEBS Lett       Date:  1989-04-24       Impact factor: 4.124

3.  Bromelain induces the differentiation of leukemic cells in vitro: an explanation for its cytostatic effects?

Authors:  H R Maurer; M Hozumi; Y Honma; J Okabe-Kado
Journal:  Planta Med       Date:  1988-10       Impact factor: 3.352

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Ananain: a novel cysteine proteinase found in pineapple stem.

Authors:  A D Rowan; D J Buttle; A J Barrett
Journal:  Arch Biochem Biophys       Date:  1988-11-15       Impact factor: 4.013

Review 6.  Cathepsin B, Cathepsin H, and cathepsin L.

Authors:  A J Barrett; H Kirschke
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  A new staining technique for proteins in polyacrylamide gels using coomassie brilliant blue G250.

Authors:  R W Blakesley; J A Boezi
Journal:  Anal Biochem       Date:  1977-10       Impact factor: 3.365

8.  Bromelain proteinases modulate the cd44 expression on human molt-4/8 leukemia and sk-mel-28 melanoma-cells in-vitro.

Authors:  T Harrach; F Gebauer; K Eckert; R Kunze; H Maurer
Journal:  Int J Oncol       Date:  1994-09       Impact factor: 5.650

9.  Inhibition of tumour growth in vitro by bromelain, an extract of the pineapple plant (Ananas comosus).

Authors:  S J Taussig; J Szekerczes; S Batkin
Journal:  Planta Med       Date:  1985-12       Impact factor: 3.352

10.  Complete structure of the carbohydrate moiety of stem bromelain. An application of the almond glycopeptidase for structural studies of glycopeptides.

Authors:  H Ishihara; N Takahashi; S Oguri; S Tejima
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

View more
  11 in total

Review 1.  Systemic enzyme therapy in oncology: effect and mode of action.

Authors:  J Leipner; R Saller
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

2.  Bromelain-Functionalized Multiple-Wall Lipid-Core Nanocapsules: Formulation, Chemical Structure and Antiproliferative Effect Against Human Breast Cancer Cells (MCF-7).

Authors:  Catiúscia P Oliveira; Willian A Prado; Vladimir Lavayen; Sabrina L Büttenbender; Aline Beckenkamp; Bruna S Martins; Diogo S Lüdtke; Leandra F Campo; Fabiano S Rodembusch; Andréia Buffon; Adalberto Pessoa; Silvia S Guterres; Adriana R Pohlmann
Journal:  Pharm Res       Date:  2016-12-15       Impact factor: 4.200

3.  Bromelain reversibly inhibits invasive properties of glioma cells.

Authors:  B B Tysnes; H R Maurer; T Porwol; B Probst; R Bjerkvig; F Hoover
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

4.  Bromelain and acetylcysteine (BromAc®) alone and in combination with gemcitabine inhibit subcutaneous deposits of pancreatic cancer after intraperitoneal injection.

Authors:  Ahmad H Mekkawy; Krishna Pillai; Hyerim Suh; Samina Badar; Javed Akhter; Vahan Képénékian; Kevin Ke; Sarah J Valle; David L Morris
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

5.  Purification and characterization of hieronymain III. Comparison with other proteases previously isolated from Bromelia hieronymi Mez.

Authors:  Mariela A Bruno; Sebastián A Trejo; Néstor O Caffini; Laura M I López
Journal:  Protein J       Date:  2008-12       Impact factor: 2.371

6.  Antiangiogenesis, loss of cell adhesion and apoptosis are involved in the antitumoral activity of Proteases from V. cundinamarcensis (C. candamarcensis) in murine melanoma B16F1.

Authors:  Dalton Dittz; Cinthia Figueiredo; Fernanda O Lemos; Celso T R Viana; Silvia P Andrade; Elaine M Souza-Fagundes; Ricardo T Fujiwara; Carlos E Salas; Miriam T P Lopes
Journal:  Int J Mol Sci       Date:  2015-03-27       Impact factor: 5.923

7.  Bromelain surface modification increases the diffusion of silica nanoparticles in the tumor extracellular matrix.

Authors:  Alessandro Parodi; Seth G Haddix; Nima Taghipour; Shilpa Scaria; Francesca Taraballi; Armando Cevenini; Iman K Yazdi; Claudia Corbo; Roberto Palomba; Sm Z Khaled; Jonathan O Martinez; Brandon S Brown; Lucas Isenhart; Ennio Tasciotti
Journal:  ACS Nano       Date:  2014-09-17       Impact factor: 15.881

8.  Properties and therapeutic application of bromelain: a review.

Authors:  Rajendra Pavan; Sapna Jain; Ajay Kumar
Journal:  Biotechnol Res Int       Date:  2012-12-10

9.  LC-MS/MS Identification of a Bromelain Peptide Biomarker from Ananas comosus Merr.

Authors:  Eric R Secor; Steven M Szczepanek; Anurag Singh; Linda Guernsey; Prabitha Natarajan; Karim Rezaul; David K Han; Roger S Thrall; Lawrence K Silbart
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-02       Impact factor: 2.629

10.  Structures of the free and inhibitors-bound forms of bromelain and ananain from Ananas comosus stem and in vitro study of their cytotoxicity.

Authors:  Mohamed Azarkan; Erik Maquoi; François Delbrassine; Raphael Herman; Nasiha M'Rabet; Rafaèle Calvo Esposito; Paulette Charlier; Frédéric Kerff
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.